Rehydra+ Review: A $119 Price You Cannot Buy for One Month

Rehydra+ Wellness passes the test this publication is built around, and then fails the thing that test was a proxy for. Every price on the site renders in plain HTML in an ordinary shopping cart. No intake stands between you and a number. You can read what a month of semaglutide costs in about four seconds, without an account.

The number you read is $119 a month. You cannot buy one month.

The term that governs everything else

Every GLP-1 membership on the site is labeled, on the memberships page and again on each product page, as valid for six months and non-cancelable. Two independent surfaces, the same words.

That single clause converts every advertised monthly figure into a commitment several times its size, and it is the first thing anyone should know about this company.

The semaglutide tiers advertise $119, $169 and $229 a month. The real minimum purchases are $714, $1,014 and $1,374. The tirzepatide tiers advertise $169, $289 and $419. The real minimums are $1,014, $1,734 and $2,514.

There is no month-to-month membership rung anywhere on the site — not a dearer one, not a hidden one. It does not exist. When a comparison table asks us for Rehydra+'s monthly price, the honest cell is not a number; it is "no monthly rung offered", and we would rather leave it empty and labeled than fill it with a figure that describes nothing you can actually purchase.

Why we still say the price transparency is real

This is the part that would be easy to get wrong in either direction.

Publishing a price and publishing a purchasable price are different achievements, and Rehydra+ has the first without the second. But it genuinely has the first. Its whole catalog — twenty-three products, every dose, every duration — is readable to a stranger. Compare that with the operator at the other end of this batch, Lighter You, whose prices sit behind a login and whose headline number corresponds to no purchasable tier at all. Rehydra+ tells you exactly what you are being asked to commit to. Then it asks you to commit to six months of it.

So the finding is precise: the disclosure is good, the term is bad, and the term is what you are actually buying.

The only thing here you can buy once

There is one route through this site that carries no commitment: the one-time supply packs. Those are cancel-anytime by definition, because there is nothing to cancel.

They come in 4-, 8- and 12-week supplies, and there is a trap in the labeling. "Duration" on these products is supply length, not a billing cadence — a 12-week pack is one purchase of twelve weeks of medication, not three monthly charges. Read a 12-week price as a monthly one and you will overstate the cost by roughly three times; read a monthly membership figure as though it were a supply pack and you will understate the commitment by six.

Semaglutide supply packs run from $149 for four weeks at 0.25 mg up to $289 at 2.5 mg, with 8-week packs from $269 to $499 and 12-week packs from $399 to $749. Tirzepatide runs $219 to $649 for four weeks, $379 to $939 for eight, and $569 to $1,419 for twelve — with no 12-week option at the 10 mg or 12.5 mg doses.

Prices on the wider peptide shelf: BPC-157 $320 to $499, a BPC-157 and TB-500 stack $380 to $559, KPV $320 to $499, sermorelin $250 to $449, tesamorelin $399 to $899, GHK-Cu $220 to $329, MOTS-c $399, NAD+ $279 to $619, and Lipo-Plus $149 to $219. Testosterone is $399 for a ten-week course.

The catalog decisions we would question

Two, and they are separate concerns.

Oral peptides. Rehydra+ sells BPC-157, KPV and tesamorelin in oral formulations alongside injectable ones. Oral bioavailability for these peptides is not established — the question is not whether they are legal to compound but whether a swallowed dose survives to do anything, and that is not a settled matter with published human pharmacokinetics behind it. Selling a route whose absorption is unresolved, at the same price bracket as the injectable, is a catalog decision worth noticing.

Testosterone in a shopping cart. Testosterone is a Schedule III controlled substance in the United States, and here it is a WooCommerce line item with an add-to-cart button, priced at $399 for ten weeks. There is a clinical review behind the purchase, as there is for everything else on the site. But the interface is a checkout, and the sequencing that interface implies — pay first, be assessed second — is a real thing about how this business is arranged rather than a design quibble.

Who prescribes, and who compounds

Three clinicians are named: John H. Hamilton, MD, the medical director; Angie Tuzson, NP; and Jared Folwell, MD. That is more than most of this cohort publishes, and it deserves the credit.

No NPI is published for any of them, so none of the three can be looked up in the national provider registry.² The pharmacy is never named at all — it is "our pharmacy partner", a phrase that names a relationship rather than a counterparty. For compounded medicine, the identity of the compounding pharmacy is the fact that most determines what is in the vial, and it is unavailable here.

The legal entity is given as "RealHealth Ventures PLLS dba Rehydra+ Wellness" in San Antonio, Texas. We are reproducing the spelling as the site publishes it.

States, certification, and financing

States. The about page says the company serves patients in twenty states. The twenty are never named. The only list of states anywhere on the site is the country's full complement in a checkout address dropdown, which is a form control rather than a coverage claim. So the served states are, for our purposes, not disclosed.

Certification. The site claims a certification in prose. The badge next to that claim is a JPEG hosted in the site's own uploads folder, and it links to a keyword search rather than to a certificate, with no seal identifier of any kind. We want to be exact about what that means: it means we could not verify the claim, not that the claim is false. Certification bodies publish verifiable seals; this is not one, and that is all we can say.

Financing. Purchases can be split through a buy-now-pay-later provider. A 2.99% processing fee applies to card down payments, and that fee is disclosed on the payment-plan page only — not on the product pages where you decide. There are no returns or refunds on prescription or compounded medication once shipped, and because the site is a cart, you pay before a provider reviews you. The refund policy does not clearly address what happens if you are not approved.

The regulatory screen

We queried the FDA's live warning-letter index for the brand and for its legal entity. Nothing matched in the company column.³ The pass carried a positive control — an unrelated telehealth seller with a real 2026 letter, which returned correctly — because an empty result from a broken query and an empty result from a clean record look identical.

That is a genuine pass and we will not imply otherwise. It is also worth saying plainly what a clean warning-letter screen is and is not: it is evidence that a company has not received a particular kind of public enforcement letter. It is not a quality certification and it is not a substitute for the pharmacy disclosure that is missing here.

Why a six-month lock is the wrong shape for this particular drug

This is where a gut-health publication has something specific to add.

The commonest adverse events on a GLP-1 are gastrointestinal — nausea, vomiting, diarrhea, constipation — and in the pivotal semaglutide trials they were both the most frequent events and a meaningful driver of people discontinuing.⁴ Tolerance is highly individual, it declares itself in the first weeks of titration, and there is no way to know in advance which side of it you fall on.

A six-month non-cancelable contract asks you to make that bet before you have any information about it. Every other structure in this batch — a monthly rung, a no-commitment tier, even a plain one-time supply pack — lets you find out cheaply and stop. This one does not. If you want to understand what you would be committing to, what a GLP-1 actually does to your digestion and how bloating behaves during titration are the two things to read first, and the one-time supply packs are the only part of this catalog that lets you act on what you learn.

Where it lands

Rehydra+ Wellness publishes everything and commits you to six months of it. It names three clinicians and no pharmacy. It claims twenty states and lists none. It claims a certification we could not verify from anything it publishes.

We take no commission from it, there is no tracking link in this article, and we would not be paid if you bought from it. If the open-cart transparency is what appeals to you, The Edit and Trellis Vitality publish comparably readable ladders with month-to-month rungs behind them, and Auren Rx prints an explicit no-commitment price on every product it sells. The full set is indexed alongside our prescription GLP-1 reviews. None of these operators is a program this site links out to; the ones that are, ranked on whether the advertised figure is the figure you are actually charged, are in our GLP-1 telehealth ranking.